Double Germline Mutations in the RET Proto-oncogene in MEN 2A and MEN 2B Kindreds

S. Dvorakova; E. Vaclavikova; A. Ryska; J. Cap; P. Vlcek; J. Duskova; D. Kodetova; V. Holub; Z. Novak; B. Bendlova

doi:10.1055/s-2006-924071

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2006; 114(4): 192-196
DOI: 10.1055/s-2006-924071

Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Double Germline Mutations in the RET Proto-oncogene in MEN 2A and MEN 2B Kindreds

S. Dvorakova¹ , E. Vaclavikova¹ , A. Ryska² , J. Cap² , P. Vlcek³ , J. Duskova⁴ , D. Kodetova⁵ , V. Holub¹ , Z. Novak¹ , B. Bendlova¹

¹Institute of Endocrinology, Prague 1, Czech Republic
²Charles University Medical Faculty and Faculty Hospital, Hradec Kralove, Czech Republic
³Department of Nuclear Medicine and Endocrinology, Charles University, Prague 5, Czech Republic
⁴Institute of Pathology, Charles University, Prague 1, Czech Republic
⁵Department of Molecular Medicine and Pathology, Charles University, Prague 5, Czech Republic

Abstract

Full Text

References

1 Bartsch D K, Hasse C, Schug C, Barth P, Rothmund M, Hoppner W. A RET double mutation in the germline of a kindred with FMTC. Exp Clin Endocrinol Diabetes. 2000; 108 128-132
2 Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M, Raue F, Ritter M M, Hoppner W. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab. 1998; 83 770-774
3 Brauer V F, Scholz G H, Neumann S, Lohmann T, Paschke R, Koch C A. RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed?. Endocr Pract. 2004; 10 5-9
4 Fitze G, Schierz M, Bredow J, Saeger H D, Roesner D, Schackert H K. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations. Ann Surg. 2002; 236 570-575
5 Gimm O, Niederle B E, Weber T, Bockhorn M, Ukkat J, Brauckhoff M, Thanh P N, Frilling A, Klar E, Niederle B, Dralle H. RET proto-oncogene mutations affecting codon 790/791: a mild form of multiple endocrine neoplasia type 2A syndrome?. Surgery. 2002; 132 952-959
6 Hansford J R, Mulligan L M. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet. 2000; 37 817-827
7 Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, Fertitta A, Carrano A V, Nagao M. Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene. 1989; 4 1519-1521
8 Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G, Takahashi M. Biological properties of ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Cancer Res. 1997; 57 2870-2872
9 Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajita H, Takahashi M. Biological and biochemical properties of ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene. 1999; 18 3919-3922
10 Jindrichova S, Vcelak J, Vlcek P, Neradilova M, Nemec J, Bendlova B. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic. J Endocrinol. 2004; 183 257-265
11 Kitamura Y, Scavarda N, Wells Jr S A, Jackson C E, Goodfellow P J. Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. Hum Mol Genet. 1995; 4 1987-1988
12 Koch C A, Huang S C, Vortmeyer A O, Zhuang Z, Chrousos G P, Pacak K. A patient with MEN 2 and multiple mutations of RET in the germline. Exp Clin Endocrinol Diabetes. 2000; 108 493
13 Menko F H, van der Luijt R B, de Valk I A, Toorians A W, Sepers J M, van Diest P J, Lips C J. Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab. 2002; 87 393-397
14 Miyauchi A, Futami H, Hai N, Yokozawa T, Kuma K, Aoki N, Kosugi S, Sugano K, Yamaguchi K. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res. 1999; 90 1-5
15 Nunes A B, Ezabella M C, Pereira A C, Krieger J E, Toledo S P. A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma. J Clin Endocrinol Metab. 2002; 87 5658-5661
16 Poturnajova M, Altanerova V, Kostalova L, Breza J, Altaner C. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome. J Mol Med. 2005; 83 287-295
17 Robledo M, Gil L, Pollan M, Cebrian A, Ruiz S, Azanedo M, Benitez J, Menarguez J, Rojas J M. Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A. Cancer Res. 2003; 63 1814-1817
18 Tessitore A, Sinisi A A, Pasquali D, Cardone M, Vitale D, Bellastella A, Colantuoni V. A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene. J Clin Endocrinol Metab. 1999; 84 3522-3527

S. Dvorakova

Institute of Endocrinology
Department of Molecular Endokrinology

Narodni 8

Prague 1

Czech Republic

Phone: + 420224905301

Fax: + 42 02 24 90 53 25

Email: sarka@obloha.cz